CHALFONT ST. GILES, England & WALTHAM, Mass.--(BUSINESS WIRE)--GE Healthcare Life Sciences, (NYSE: GE), and NetBio named today several of the laboratories participating in the recently announced comprehensive developmental validation of DNAscan™ Rapid DNA Analysis™ System. Leading international and US accredited NDIS participating forensic laboratories are independently evaluating the overall system from “swab-in to profile-out”, including the on-board Expert System software which uses automated data interpretation to eliminate the need for human review.
Help employers find you! Check out all the jobs and post your resume.